Waldencast plc (WALD)
- Previous Close
4.5400 - Open
4.5900 - Bid 4.3200 x 100
- Ask 4.4500 x 100
- Day's Range
4.1900 - 4.6762 - 52 Week Range
4.1900 - 12.0000 - Volume
170,603 - Avg. Volume
87,215 - Market Cap (intraday)
531.522M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-0.9900 - Earnings Date Mar 21, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
8.00
Waldencast plc operates in the beauty and wellness industry. It engages in developing, acquiring, accelerating, and scaling various brands. The company provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians. It also offers clean makeup products under the Milk Makeup brand. The company sells its products to dermatologists, plastic surgeons, and other physicians who focuses on aesthetic and therapeutic skincare, including physicians on site at medical spas, through its direct sales force, as well as through distribution partners. Waldencast plc was incorporated in 2020 and is headquartered in White Plains, New York.
www.waldencast.com284
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: WALD
Performance Overview: WALD
Trailing total returns as of 5/17/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: WALD
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: WALD
Valuation Measures
Market Cap
531.52M
Enterprise Value
688.16M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.82
Price/Book (mrq)
0.85
Enterprise Value/Revenue
3.15
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-41.25%
Return on Assets (ttm)
-4.80%
Return on Equity (ttm)
-13.51%
Revenue (ttm)
218.14M
Net Income Avi to Common (ttm)
-89.98M
Diluted EPS (ttm)
-0.9900
Balance Sheet and Cash Flow
Total Cash (mrq)
21.09M
Total Debt/Equity (mrq)
23.10%
Levered Free Cash Flow (ttm)
-291.12k
Research Analysis: WALD
Company Insights: WALD
WALD does not have Company Insights